Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Fiedler

Showing results (41-50 of 195) with videos related to

Pageof 20
Sort By:
Thrombosis and Haemostasis|November 16, 2004
An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSFFlorian Langer, Ali Amirkhosravi, Sonja Loges, et al.
Leukemia & Lymphoma|August 23, 2006
Detection of N-RAS and K-RAS in their active GTP-bound form in acute myeloid leukemia without activating RAS mutationsFalk Ehmann, Stefan Horn, Lizet Garcia-Palma, et al.
Annals of Hematology|October 27, 2020
Newly diagnosed isolated myeloid sarcoma-paired NGS panel analysis of extramedullary tumor and bone marrowNils W Engel, Jochim Reinert, Nora M Borchert, et al.
Leukemia & Lymphoma|August 8, 2023
The prognostic impact of lymphoma perforation in patients with primary gastrointestinal lymphoma - a single-center analysisFranziska Modemann, Paymon Ahmadi, Philipp H von Kroge, et al.
Annals of Hematology|August 1, 2021
The BET bromodomain inhibitor ZEN-3365 targets the Hedgehog signaling pathway in acute myeloid leukemiaJasmin Wellbrock, Lena Behrmann, Jana Muschhammer, et al.
Cancers|July 1, 2020
Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre AnalysisPanagiotis Karagiannis, Lena Sänger, Winfried Alsdorf, et al.
Biochemical and Biophysical Research Communications|May 1, 2007
Cilengitide inhibits proliferation and differentiation of human endothelial progenitor cells in vitroSonja Loges, Martin Butzal, Jasmin Otten, et al.
Haematologica|September 2, 2018
Continuous high dosing of lenalidomide in relapsed, refractory or older newly diagnosed acute myeloid leukemia patients not suitable for other treatment options - results from a phase I studyMarie Luise Hütter-Krönke, Walter Fiedler, Andrea Kündgen, et al.
British Journal of Haematology|May 15, 2008
Blood outgrowth endothelial cells from chronic myeloid leukaemia patients are BCR/ABL1 negativeJasmin Otten, Alexander Schultze, Philippe Schafhausen, et al.
Leukemia Research|June 3, 2008
PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinasesArtur Gontarewicz, Stefan Balabanov, Gunhild Keller, et al.
Pageof 20

Showing results (41-50 of 195) with videos related to

Sort By:
Pageof 20
Thrombosis and Haemostasis|November 16, 2004
An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSFFlorian Langer, Ali Amirkhosravi, Sonja Loges, et al.
Leukemia & Lymphoma|August 23, 2006
Detection of N-RAS and K-RAS in their active GTP-bound form in acute myeloid leukemia without activating RAS mutationsFalk Ehmann, Stefan Horn, Lizet Garcia-Palma, et al.
Annals of Hematology|October 27, 2020
Newly diagnosed isolated myeloid sarcoma-paired NGS panel analysis of extramedullary tumor and bone marrowNils W Engel, Jochim Reinert, Nora M Borchert, et al.
Leukemia & Lymphoma|August 8, 2023
The prognostic impact of lymphoma perforation in patients with primary gastrointestinal lymphoma - a single-center analysisFranziska Modemann, Paymon Ahmadi, Philipp H von Kroge, et al.
Annals of Hematology|August 1, 2021
The BET bromodomain inhibitor ZEN-3365 targets the Hedgehog signaling pathway in acute myeloid leukemiaJasmin Wellbrock, Lena Behrmann, Jana Muschhammer, et al.
Cancers|July 1, 2020
Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre AnalysisPanagiotis Karagiannis, Lena Sänger, Winfried Alsdorf, et al.
Biochemical and Biophysical Research Communications|May 1, 2007
Cilengitide inhibits proliferation and differentiation of human endothelial progenitor cells in vitroSonja Loges, Martin Butzal, Jasmin Otten, et al.
Haematologica|September 2, 2018
Continuous high dosing of lenalidomide in relapsed, refractory or older newly diagnosed acute myeloid leukemia patients not suitable for other treatment options - results from a phase I studyMarie Luise Hütter-Krönke, Walter Fiedler, Andrea Kündgen, et al.
British Journal of Haematology|May 15, 2008
Blood outgrowth endothelial cells from chronic myeloid leukaemia patients are BCR/ABL1 negativeJasmin Otten, Alexander Schultze, Philippe Schafhausen, et al.
Leukemia Research|June 3, 2008
PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinasesArtur Gontarewicz, Stefan Balabanov, Gunhild Keller, et al.
Pageof 20